IDIAPJGol Calls - ICS 2023 Internal Grants is open

From August 1st and until November 3rd, you can apply for the 2023 Primary Health Care Research Grants, promoted by Institut Universitari d'Investigació en Atenció Primària de Salut Jordi Gol (IDIAPJGol) in collaboration with Institut Català de la Salut (ICS).

Health Department grants us one of the nine Go Europe subsidies to promote internationalization

The funds will allow the incorporation of new professionals to improve the support we give to research staff when participating in international calls, organizing courses and conferences or subsidizing consultancies, with the aim of promoting IDIAPJGol's research and innovation projects at European level.

Rosa Morros: "What satisfies me the most is to keep learning"

The specialist in Clinical Pharmacology and PhD in Pharmacology arrived at the IDIAPJGol in 2009 and is the head of the Medicine Studies Unit (UEM). In her busy schedule there is also room to perform the duties of president of the Clinical Research Ethics Committee.

Latest scientific papers published

During the month of July, the IDIAPJGol research staff published 19 new articles in national and international scientific journals. You can consult them below.

We participate in a European study on pharmacovigilance through VAC4EU

The IDIAPJGol has participated and contributed, through Vaccine monitoring Collaboration for Europe (VAC4EU), to the Report on pharmacovigilance tasks study, which summarizes the work carried out by the EU Pharmacovigilance Network between January 2019 and December 2022 to guarantee the safety of all medicines authorized in the EU, including vaccines and therapeutics against COVID-19. The report also describes the main improvements introduced to the EU pharmacovigilance system during this period and critically reflects on the main areas that will need to be further strengthened in the coming period.

IDIAPJGol has participated and contributed, through the Vaccine monitoring Collaboration for Europe (VAC4EU), to the study Report on pharmacovigilance tasks, which summarizes the work carried out by the EU Pharmacovigilance Network between January 2019 and December 2022 to guarantee the safety of all medicines authorized in the EU, including vaccines and therapeutics against COVID-19. The report also describes the main improvements introduced in the pharmacovigilance system of the EU during this period and reflects critically on the main areas that will have to be strengthened even more in the next period.

 

A study makes it possible to calculate for the first time the cardiovascular risk in people with diabetes 2

It is the result of the SCORE2-Diabetes project developed in four European regions, with the participation of IDIAPJGol and CIBERDEM. Its implementation will make it possible to prevent, diagnose complications early and start treatments that reduce the risk of cardiovascular problems among the more than 5 million people affected by this disease in Spain.